Search for: "Anda Pharmaceuticals, Inc"
Results 361 - 380
of 607
Sort by Relevance
|
Sort by Date
26 Jun 2011, 8:59 pm
In 2008, Minrad, Inc. [read post]
22 Jun 2011, 2:11 pm
Mutual Pharmaceutical. [read post]
22 Jun 2011, 4:09 am
A-G’s opinion published – Merck & Co Inc. v Deutsches Patent- und Markenamt (EPLAW) (The SPC Blog) US: Supreme Court to revisit patentable subject matter eligibility of medical diagnostic methods: Mayo v Prometheus (Patently-O) (Patent Baristas) (PharmaPatents) (IPBiz) (Patent Law Practice Center) US: Intellectual property problems for personalized medicine (BIOtechNow) US: Supreme Court ruling in Stanford v Roche (IPKat) (IPKat) US: Manager’s Amendment (and… [read post]
19 Jun 2011, 9:18 pm
Somaxon Pharmaceuticals Inc. et al. v. [read post]
14 Jun 2011, 9:24 pm
• Defendants: Mylan Inc.; Mylan Pharmaceuticals, Inc. [read post]
13 Jun 2011, 5:32 pm
Several other generic drug manufacturers submitted ANDAs to FDA containing Paragraph IV certifications to Orange Book-listed patents on GEMZAR, including APP Pharmaceuticals, Inc. [read post]
12 Jun 2011, 9:17 pm
.; Par Pharmaceutical Inc. [read post]
9 Jun 2011, 10:16 am
Indianapolis, IN - Patent lawyers for Alcon Research Ltd of Fort Worth, Texas, Alcon Pharmaceuticals LTD of Switzerland, and Kyowa Haddo Kirin Co. of Japan filed a patent infringement in alleging Watson Laboratories Inc and Watson Pharma, Inc. of Parsippany, New Jersey, and Watson Laboratories, of Corona, California, infringed the following patent prior to the expiration: Patent No. 5,641,805, Topical ophthalmic formulations for treating allergic eye diseases, Patent No.… [read post]
1 Jun 2011, 5:51 pm
Karst – Last week, in a seven-page response, FDA denied an October 18, 2010 Citizen Petition submitted on behalf of Lupin Limited (“Lupin”) requesting that FDA determine that Teva Pharmaceuticals USA, Inc. [read post]
30 May 2011, 6:34 pm
Karst – Last Friday, Nostrum Pharmaceuticals, LLC (“Nostrum”) lodged a Complaint against FDA in the U.S. [read post]
23 May 2011, 9:59 pm
• Defendants: Impax Laboratories, Inc.; Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries Ltd. [read post]
19 May 2011, 9:12 pm
Teleflex, Inc., 550 U.S. 398, 421 (2007). [read post]
17 May 2011, 5:51 am
Karst – Last Friday, ISTA Pharmaceuticals, Inc. [read post]
15 May 2011, 8:55 pm
• Defendant: Teva Pharmaceuticals USA Inc. [read post]
15 May 2011, 2:54 pm
LLC, Watson Pharmaceuticals, Inc., and Synthon Holding B.V. notifying them that the Bureau believes the companies violated federal law by failing to inform antitrust authorities about patent agreements involving Sanofi’s insomnia drug AMBIEN CR (zolpidem tartrate) Tablets, but that instead of recommending that the FTC take enforcement action, it would issue advisory letters. [read post]
11 May 2011, 4:54 am
Allergan, Inc. [read post]
10 May 2011, 4:24 pm
LLC, Watson Pharmaceuticals, Inc., and Synthon Holding B.V., that it believes the companies violated federal law by failing to inform antitrust authorities about drug patent agreements involving Sanofi's insomnia drug Ambien CR. [read post]
27 Apr 2011, 6:44 am
Mylan Pharmaceuticals, Inc., C.A. [read post]
25 Apr 2011, 3:16 pm
The following is excerpted from an April 25, 2010 press release from POZEN published by Business Wire: POZEN Inc. [read post]
13 Apr 2011, 5:13 pm
Ortho-McNeil-Janssen Pharmaceuticals, Inc., No. 2-10-cv-00836 (E.D. [read post]
